+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Advanced Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cervical Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 160 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 1400 Pages
  • Global
From
From
Oncolytic Virus - Competitive Landscape, 2022 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2022

  • Report
  • October 2022
  • 300 Pages
  • Global
From
From
Pancreatic Cancer - Competitive Landscape, 2024 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 550 Pages
  • Global
From
From
From
From
From
From
Loading Indicator